We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
As part of its "Road Map to 2010," the European Medicines
Agency (EMEA) and European Union (EU) national drug regulators have published
a new set of strategic plans.
GlaxoSmithKline has confirmed it is changing the way its business is structured
in New Zealand, and is in discussions with staff. In the late 1990s the pharmaceutical
company, then called Glaxo Wellcome, reduced its workforce, making 46 staff
redundant.
Health Canada is advising consumers of important information about the use of
the prescription drug DIANE-35. Berlex and Health Canada reached an agreement
on a new version of the Product Monograph.
Galapagos NV, a genomics-based drug discovery company and Asinex, a worldwide
leader in lead generation and optimization announce that they have initiated
an integrated drug discovery collaboration in bone and joint diseases.
Debiopharm S.A., the independent
drug-development company specialising in oncology, endocrinology and niche products,
is pleased to acknowledge a new marketing and supply agreement between Paladin
Labs, a leading Canadian specialty pharmaceutical company and Watson Pharma,
Inc., a subsidiary of Watson Pharmaceuticals, Inc. (Watson) to market Trelstar
3.75 mg and Trelstar LA 11.25 mg (triptorelin pamoate for injectable suspension)
in Canada.
Scientists at the Harvard School of Public Health have condemned
misleading US promotional material distributed by controversial vitamins supplier
the Dr Rath foundation.
Brazilian pharmacy groups have criticised new regulations issued by national
drug regulator Anvisa, aiming to tighten rules on dispensing and the availability
of essential generic medicines.